Literature DB >> 27817025

Expression of the FAP gene in non-fibroblast human cell lines. Development of cancer-associated fibroblast models.

D V Tyulkina1, V V Pleshkan2, I V Alekseenko2, M R Kopantseva2, E D Sverdlov2.   

Abstract

The fibroblast activation protein (FAP) is selectively expressed in cancer-associated fibroblasts (CAFs) and facilitates tumor progression, which makes this protein an attractive therapeutic target. There are difficulties in obtaining CAFs for studying the function and suppression of FAP. In this work, the expression level of FAP was determined by PCR assay in 25 human cell lines and 8 surgical samples of tumor stroma. The expression of FAP was observed in all tumor stroma samples and in four cell lines: NGP-127, SJCRH30, SJSA-1, and A375. The level of FAP expression in NGP-127, SJCRH30, and SJSA-1 lines as well as in CAFs of patients was comparable, which makes these cell lines a possible model for studying FAP.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27817025     DOI： 10.1134/S1607672916050033

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


  13 in total

1.  Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors.

Authors:  Peter C Hollenhorst; David A Jones; Barbara J Graves
Journal:  Nucleic Acids Res       Date:  2004-10-21       Impact factor: 16.971

2.  Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.

Authors:  Albert Lo; Liang-Chuan S Wang; Steven M Albelda; Ellen Puré; John Scholler; James Monslow; Diana Avery; Kheng Newick; Shaun O'Brien; Rebecca A Evans; David J Bajor; Cynthia Clendenin; Amy C Durham; Elizabeth L Buza; Robert H Vonderheide; Carl H June
Journal:  Cancer Res       Date:  2015-05-15       Impact factor: 12.701

3.  Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.

Authors:  P Garin-Chesa; L J Old; W J Rettig
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Chromosomal aberrations in human neuroblastomas.

Authors:  G M Brodeur; G Sekhon; M N Goldstein
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

5.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

6.  Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Tamyra D Downs; Patrick A McKee
Journal:  Neoplasia       Date:  2013-04       Impact factor: 5.715

Review 7.  Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy.

Authors:  Elizabeth J Hamson; Fiona M Keane; Stefan Tholen; Oliver Schilling; Mark D Gorrell
Journal:  Proteomics Clin Appl       Date:  2014-03-24       Impact factor: 3.494

8.  Amplification of the gli gene in childhood sarcomas.

Authors:  W M Roberts; E C Douglass; S C Peiper; P J Houghton; A T Look
Journal:  Cancer Res       Date:  1989-10-01       Impact factor: 12.701

9.  Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.

Authors:  Kenneth W Jackson; Victoria J Christiansen; Vivek R Yadav; Robert Silasi-Mansat; Florea Lupu; Vibhudutta Awasthi; Roy R Zhang; Patrick A McKee
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

10.  Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia.

Authors:  Eric Tran; Dhanalakshmi Chinnasamy; Zhiya Yu; Richard A Morgan; Chyi-Chia Richard Lee; Nicholas P Restifo; Steven A Rosenberg
Journal:  J Exp Med       Date:  2013-05-27       Impact factor: 14.307
View more
  4 in total

1.  BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins.

Authors:  Meng Jiang; Yue Kang; Tomasz Sewastianik; Jiao Wang; Helen Tanton; Keith Alder; Peter Dennis; Yu Xin; Zhongqiu Wang; Ruiyang Liu; Mengyun Zhang; Ying Huang; Massimo Loda; Amitabh Srivastava; Runsheng Chen; Ming Liu; Ruben D Carrasco
Journal:  Nat Commun       Date:  2020-01-07       Impact factor: 14.919

2.  Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-κB pathway to promote metastasis.

Authors:  Ziming Yuan; Hanqing Hu; Yihao Zhu; Weiyuan Zhang; Qingxiao Fang; Tianyu Qiao; Tianyi Ma; Meng Wang; Rui Huang; Qingchao Tang; Feng Gao; Chaoxia Zou; Xu Gao; Guiyu Wang; Xishan Wang
Journal:  Cell Death Dis       Date:  2021-05-25       Impact factor: 8.469

Review 3.  Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics.

Authors:  Ellen Puré; Rachel Blomberg
Journal:  Oncogene       Date:  2018-05-03       Impact factor: 9.867

4.  Copy Number Alterations in Hepatoblastoma: Literature Review and a Brazilian Cohort Analysis Highlight New Biological Pathways.

Authors:  Juliana Sobral Barros; Talita Ferreira Marques Aguiar; Silvia Souza Costa; Maria Prates Rivas; Monica Cypriano; Silvia Regina Caminada Toledo; Estela Maria Novak; Vicente Odone; Lilian Maria Cristofani; Dirce Maria Carraro; Isabela Werneck da Cunha; Cecília Maria Lima Costa; Angela M Vianna-Morgante; Carla Rosenberg; Ana Cristina Victorino Krepischi
Journal:  Front Oncol       Date:  2021-12-08       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.